Geological Characterization, Lithogeochemistry and the Metallogenic Potential for Chromium of the Riacho do Mocambo Mafic-Ultramafic Body, Northeast of the São Francisco Craton, BA, Brazil

In the geotectonic context of the Salvador-Curaçá Orogen, north portion of the São Francisco Craton, an association of mafic-ultramafic (M-UM) rocks was identified and described in this paper as the Riacho do Mocambo Mafic- Ultramafic Body (RMMUB). Despite being located approximately 60 km from the Vale do Jacurici Complex (VJC), the host of Brazil’s largest reserves of  Cr, the RMMUB has never been associated with this Complex in regional geologic mapping projects. When it is mentioned in the bibliography, the M- UM rocks of the RMMUB are genetically related to the São José do Jacuípe Suite (SJJS). While the VJC is described as differentiated sills, associated with a synorogenic to a tardi-orogenic event, the SJJS is interpreted as fragments of an Archean-Paleoproterozoic oceanic crust or as a Gabbro- Anorthosite Stratiform Complex. Such contrasting genesis raised doubts about the RMMUB’s origin and field work along with geochemical analyses were carried out in order to better understand the possible source of the RMMUB. In the field, the RMMUB exhibits an elongated shape of small thickness (7 km of extension by less than 100 m of apparent thickness), displayed concordantly with the Tanque Novo-Ipirá Complex metasediments. In the mapped outcrops it is possible to observe the rhythmic and gradual alternation amid the lithotypes of the RMMUB, varying from serpentinite to metagabbro, suggesting that it is a layered igneous body. The geochemical results support the primitive aspect of the ultramafic rocks of this body (MgO up to 38 wt.%; Ni up to 2972 ppm; Cr up to 7799 ppm) and suggest that the RMMUB shows distinctive characteristics from the SJJS, but similar ones with magma of the VJC such as geochemical signatures, source, depth, and tectonic environment. The discovery of this new M-UM body in an area of great metallogenic fertility opens a potential for the identification of new Cr mineralization and magmatic sulfides of Ni, Cu, and EGP, in the Salvador- Curaçá Orogen, São Francisco Craton, the northeast region of the state of Bahia

APICULTURA E RESPONSABILIDADE SOCIAL: DESAFIOS DA PRODUÇÃO E DIFICULDADES EM ADOTAR PRÁTICAS SOCIAL E AMBIENTALMENTE RESPONSÁVEIS

RESUMOO artigo objetiva identificar a percepção e as dificuldades que os produtores têm em adotar práticas mais responsáveis social e ambientalmente. Utilizou-se de método qualitativo, com entrevista semiestruturada com cinco das seis pessoas que participam da Associação de Apicultores. Nesse sentido, a pesquisa utilizou a análise categorial temática, com o desmembramento em categorias conforme os temas que emergem do texto identificando o que eles têm em comum, dividida em quatro categorias temáticas: 3.1 - Perfil dos entrevistados; 3.2 - Determinação da criação de abelhas e da produção do mel; 3.3 - Conhecimento da atividade e importância da associação; 3.4 - Comercialização e responsabilidade social e ambiental. A responsabilidade social em relação ao mel foi evidenciada como um diferencial no produto concentrado nas preocupações com o meio ambiente, influenciando as tomadas de decisões dos apicultores em seus negócios, bem como no comprometimento para a melhoria da qualidade de vida e bem-estar social. Os resultados da pesquisa também demonstraram que a apicultura é uma atividade lucrativa. No entanto, se percebeu que, em decorrência dos associados não estarem bem organizados, têm dificuldades em comercializar seus produtos

Pervasive gaps in Amazonian ecological research

Biodiversity loss is one of the main challenges of our time,1,2 and attempts to address it require a clear un derstanding of how ecological communities respond to environmental change across time and space.3,4 While the increasing availability of global databases on ecological communities has advanced our knowledge of biodiversity sensitivity to environmental changes,5–7 vast areas of the tropics remain understudied.8–11 In the American tropics, Amazonia stands out as the world’s most diverse rainforest and the primary source of Neotropical biodiversity,12 but it remains among the least known forests in America and is often underrepre sented in biodiversity databases.13–15 To worsen this situation, human-induced modifications16,17 may elim inate pieces of the Amazon’s biodiversity puzzle before we can use them to understand how ecological com munities are responding. To increase generalization and applicability of biodiversity knowledge,18,19 it is thus crucial to reduce biases in ecological research, particularly in regions projected to face the most pronounced environmental changes. We integrate ecological community metadata of 7,694 sampling sites for multiple or ganism groups in a machine learning model framework to map the research probability across the Brazilian Amazonia, while identifying the region’s vulnerability to environmental change. 15%–18% of the most ne glected areas in ecological research are expected to experience severe climate or land use changes by 2050. This means that unless we take immediate action, we will not be able to establish their current status, much less monitor how it is changing and what is being lostinfo:eu-repo/semantics/publishedVersio

The Changing Landscape for Stroke\ua0Prevention in AF: Findings From the GLORIA-AF Registry Phase 2

Background GLORIA-AF (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation) is a prospective, global registry program describing antithrombotic treatment patterns in patients with newly diagnosed nonvalvular atrial fibrillation at risk of stroke. Phase 2 began when dabigatran, the first non\u2013vitamin K antagonist oral anticoagulant (NOAC), became available. Objectives This study sought to describe phase 2 baseline data and compare these with the pre-NOAC era collected during phase 1. Methods During phase 2, 15,641 consenting patients were enrolled (November 2011 to December 2014); 15,092 were eligible. This pre-specified cross-sectional analysis describes eligible patients\u2019 baseline characteristics. Atrial fibrillation disease characteristics, medical outcomes, and concomitant diseases and medications were collected. Data were analyzed using descriptive statistics. Results Of the total patients, 45.5% were female; median age was 71 (interquartile range: 64, 78) years. Patients were from Europe (47.1%), North America (22.5%), Asia (20.3%), Latin America (6.0%), and the Middle East/Africa (4.0%). Most had high stroke risk (CHA2DS2-VASc [Congestive heart failure, Hypertension, Age  6575 years, Diabetes mellitus, previous Stroke, Vascular disease, Age 65 to 74 years, Sex category] score  652; 86.1%); 13.9% had moderate risk (CHA2DS2-VASc = 1). Overall, 79.9% received oral anticoagulants, of whom 47.6% received NOAC and 32.3% vitamin K antagonists (VKA); 12.1% received antiplatelet agents; 7.8% received no antithrombotic treatment. For comparison, the proportion of phase 1 patients (of N = 1,063 all eligible) prescribed VKA was 32.8%, acetylsalicylic acid 41.7%, and no therapy 20.2%. In Europe in phase 2, treatment with NOAC was more common than VKA (52.3% and 37.8%, respectively); 6.0% of patients received antiplatelet treatment; and 3.8% received no antithrombotic treatment. In North America, 52.1%, 26.2%, and 14.0% of patients received NOAC, VKA, and antiplatelet drugs, respectively; 7.5% received no antithrombotic treatment. NOAC use was less common in Asia (27.7%), where 27.5% of patients received VKA, 25.0% antiplatelet drugs, and 19.8% no antithrombotic treatment. Conclusions The baseline data from GLORIA-AF phase 2 demonstrate that in newly diagnosed nonvalvular atrial fibrillation patients, NOAC have been highly adopted into practice, becoming more frequently prescribed than VKA in Europe and North America. Worldwide, however, a large proportion of patients remain undertreated, particularly in Asia and North America. (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients With Atrial Fibrillation [GLORIA-AF]; NCT01468701

Pervasive gaps in Amazonian ecological research

Biodiversity loss is one of the main challenges of our time,1,2 and attempts to address it require a clear understanding of how ecological communities respond to environmental change across time and space.3,4 While the increasing availability of global databases on ecological communities has advanced our knowledge of biodiversity sensitivity to environmental changes,5,6,7 vast areas of the tropics remain understudied.8,9,10,11 In the American tropics, Amazonia stands out as the world's most diverse rainforest and the primary source of Neotropical biodiversity,12 but it remains among the least known forests in America and is often underrepresented in biodiversity databases.13,14,15 To worsen this situation, human-induced modifications16,17 may eliminate pieces of the Amazon's biodiversity puzzle before we can use them to understand how ecological communities are responding. To increase generalization and applicability of biodiversity knowledge,18,19 it is thus crucial to reduce biases in ecological research, particularly in regions projected to face the most pronounced environmental changes. We integrate ecological community metadata of 7,694 sampling sites for multiple organism groups in a machine learning model framework to map the research probability across the Brazilian Amazonia, while identifying the region's vulnerability to environmental change. 15%–18% of the most neglected areas in ecological research are expected to experience severe climate or land use changes by 2050. This means that unless we take immediate action, we will not be able to establish their current status, much less monitor how it is changing and what is being lost

Rationale, study design, and analysis plan of the Alveolar Recruitment for ARDS Trial (ART): Study protocol for a randomized controlled trial

Background: Acute respiratory distress syndrome (ARDS) is associated with high in-hospital mortality. Alveolar recruitment followed by ventilation at optimal titrated PEEP may reduce ventilator-induced lung injury and improve oxygenation in patients with ARDS, but the effects on mortality and other clinical outcomes remain unknown. This article reports the rationale, study design, and analysis plan of the Alveolar Recruitment for ARDS Trial (ART). Methods/Design: ART is a pragmatic, multicenter, randomized (concealed), controlled trial, which aims to determine if maximum stepwise alveolar recruitment associated with PEEP titration is able to increase 28-day survival in patients with ARDS compared to conventional treatment (ARDSNet strategy). We will enroll adult patients with ARDS of less than 72 h duration. The intervention group will receive an alveolar recruitment maneuver, with stepwise increases of PEEP achieving 45 cmH(2)O and peak pressure of 60 cmH2O, followed by ventilation with optimal PEEP titrated according to the static compliance of the respiratory system. In the control group, mechanical ventilation will follow a conventional protocol (ARDSNet). In both groups, we will use controlled volume mode with low tidal volumes (4 to 6 mL/kg of predicted body weight) and targeting plateau pressure <= 30 cmH2O. The primary outcome is 28-day survival, and the secondary outcomes are: length of ICU stay; length of hospital stay; pneumothorax requiring chest tube during first 7 days; barotrauma during first 7 days; mechanical ventilation-free days from days 1 to 28; ICU, in-hospital, and 6-month survival. ART is an event-guided trial planned to last until 520 events (deaths within 28 days) are observed. These events allow detection of a hazard ratio of 0.75, with 90% power and two-tailed type I error of 5%. All analysis will follow the intention-to-treat principle. Discussion: If the ART strategy with maximum recruitment and PEEP titration improves 28-day survival, this will represent a notable advance to the care of ARDS patients. Conversely, if the ART strategy is similar or inferior to the current evidence-based strategy (ARDSNet), this should also change current practice as many institutions routinely employ recruitment maneuvers and set PEEP levels according to some titration method.Hospital do Coracao (HCor) as part of the Program 'Hospitais de Excelencia a Servico do SUS (PROADI-SUS)'Brazilian Ministry of Healt